Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The goal of this proposal is to profile the pharmacokinetics of dexmedetomidine in newborns
≥36 weeks post-menstrual age during therapeutic hypothermia for hypoxic-ischemic
encephalopathy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Seattle Children's Hospital
Treatments:
Adrenergic alpha-2 Receptor Agonists Central Nervous System Depressants Dexmedetomidine